Document is current
Any future updates will be listed below
-
Authors
van den Bruele, Astrid Botty https://orcid.org/0000-0002-0621-980X
Williams, Austin
Weiss, Anna
,
Fayanju, Oluwadamilola M.
Agnese, Doreen M.
Bonci, Eduard-Alexandru
Grumley, Janie G. W.
Kesmodel, Susan B.
Dominici, Laura S.
Boughey, Judy C.
Dirbas, Frederick M.
- License Information
-
More Information
Article History
Received: 1 November 2024
Accepted: 11 December 2024
First Online: 13 January 2025
Disclosures
: Astrid Botty van den Bruele, MD, FACS has no disclosures to report. Anna Weiss, MD is an advisory board member/has received consulting payments from Merck, Myriad, Abbvie. Both authors are both members of the Society of Surgical Oncology Breast Disease Working Group. Austin D. Williams, MD is a consultant for Elucent Medical. Oluwadamilola M. Fayanju, MD, is supported by the National Institutes of Health (NIH) under Award Numbers 7K08CA241390-03 (PI: Fayanju) and P50CA244690 (PIs: Bekelman), the Breast Cancer Research Foundation, and philanthropic funds from the Haas family. She also reports research support unrelated to this work from Gilead Sciences, Inc. Dr. Judy Boughey receives funding paid to her institution from Eli Lilly and SymBioSis and sits on the Data Safety Monitoring Committee of CairnsSurgical. She has received honoraria from PER, PeerView, OncLive, EndoMag and Up-To-Date. Dr. Frederick M. Dirbas is a consultant and chair of the scientific advisory board of Beyond Cancer, Ltd; shareholder of Hologic, Inc; and investor and member of the medical advisory board for Silicon Valley Innovations, Inc.
Free to read: This content has been made available to all.
